Flor Juarez-Hernandez

No ORCID on file · 2 papers in corpus

rct 2022

Hormone concentrations of dominant follicles in the TALES randomized controlled trial comparing letrozole with tamoxifen

Journal of assisted reproduction and genetics ·doi:10.1007/s10815-022-02626-6

BACKGROUND: In this secondary analysis of the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) trial, we aimed to investigate if concurrent administration of letrozole vs. tamoxifen vs. no added treatment affects hormonal composi…

rct 2021

Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial

Journal of assisted reproduction and genetics ·doi:10.1007/s10815-021-02273-3

PURPOSE: To determine whether concomitant tamoxifen 20 mg with gonadotropins (tamoxifen-gonadotropin) versus letrozole 5 mg with gonadotropins (letrozole-gonadotropin) affects mature oocyte yield. METHODS: Open-label, single-institution, r…